Vitaresp FX Tablet
By Vitaresp FX
Rx
15 Tablet in a Strip

Composition
Montelukast(10mg) + Fexofenadine(120mg)

Manufacturer - Alembic Pharmaceuticals Ltd
Alembic Road, Vadodara - 390 003, Gujarat,INDIA

Expires on or after
May, 2026

liver
Vitaresp FX Tablet is likely safe for use in individuals with liver disease. From the limited data available, it appears that adjusting the dose of Vitaresp FX Tablet may not be necessary for these patients. It is important to consult your doctor regarding the use of this medication if you have liver issues.

kidney
Vitaresp FX Tablet should be used carefully by patients with kidney disease. Adjusting the dosage may be necessary. Consult your doctor before use. It may lead to increased drowsiness in those with end stage kidney disease.

alcohol
When taking Vitaresp FX Tablet, it is important to be cautious when drinking alcohol. It is recommended to consult with your doctor regarding alcohol consumption.

driving
Vitaresp FX Tablet can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Vitaresp FX Tablet should be avoided during pregnancy as it may be harmful to the developing baby based on animal studies. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Vitaresp FX Tablet is likely safe for breastfeeding moms. Limited data shows low risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹271.3
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024